Baxter International (BAX)
(Real Time Quote from BATS)
$42.94 USD
+0.25 (0.59%)
Updated Mar 28, 2024 10:50 AM ET
3-Hold of 5 3
A Value D Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BAX 42.94 +0.25(0.59%)
Will BAX be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for BAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BAX
Baxter's (BAX) Q4 Earnings Top, Sales Rise on Strong Demand
Baxter (BAX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
BAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Baxter International (BAX) Tops Q4 Earnings and Revenue Estimates
Countdown to Baxter (BAX) Q4 Earnings: Wall Street Forecasts for Key Metrics
Baxter (BAX) to Report Q4 Earnings: What's in the Cards?
Other News for BAX
Interesting BAX Put And Call Options For May 10th
Baxter to Host Annual Meeting of Stockholders in Virtual Format
3M’s healthcare spinoff Solventum begins trading
Dividend Champion, Contender, And Challenger Highlights: Week Of March 24
Becton, Dickinson And Co. Dividend Stock Analysis